Loading clinical trials...
Loading clinical trials...
The Effects of Zinc Gluconate Supplementation on Several Genes Expression, the Serum Level of Inflammatory Factors, Quality of Life, and Disease Activity in Patients With Behcet Syndrome: Double-blind Randomized Controlled Clinical Trial
Conditions
Interventions
Zinc gluconate
Placebo
Locations
1
Iran
Tabriz University of Medical Sciences
Tabriz, East Azerbaijan Province, Iran
Start Date
August 22, 2020
Primary Completion Date
May 22, 2021
Completion Date
September 22, 2021
Last Updated
November 4, 2021
NCT05200715
NCT06849908
NCT06729112
NCT05142995
NCT03554161
NCT00866359
Lead Sponsor
Tabriz University of Medical Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions